BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

LCA-Vision's LasikPlus(R) Research Reveals Excellent Results From Modern LASIK


3/30/2011 7:20:15 AM

CINCINNATI, March 30, 2011 /PRNewswire/ -- LasikPlus® surgeon Dr. Lewis Groden presented results from a first-of-its-kind, comparative study at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium revealing that LASIK procedures performed with modern excimer laser technology produce excellent results and very high patient satisfaction rates.

Each LCA-Vision (Nasdaq: LCAV) LasikPlus® vision center currently offers patients a choice of multiple state-of-the-art LASIK excimer platforms.

"Every day we witness life-transforming outcomes from this procedure and, as a company, we set out to determine scientifically whether technological advancements are producing outcomes that are as good as we believe," said Dr. Groden, surgeon at the Tampa LasikPlus® vision center and Director of Cornea Service for the University of South Florida Department of Ophthalmology.

The study included an analysis of 180 procedures performed on 90 patients, who were treated between October 20 and December 19, 2008. Three months post-operatively, 89 percent of these patients had uncorrected visual acuity of 20/20 or better, and 93 percent of these patients strongly agreed with the statement, "My vision is excellent."

LasikPlus®, in conjunction with industry collaborators,conducted the randomized study of the different state-of-the-art excimer laser technologies at three LasikPlus® vision centers. Independent calibration of the equipment was performed on each procedure day, visual acuity was determined by use of standardized vision charts and all 90 patients participated in follow-up interviews three months following their procedure. The data was analyzed by the independent research firm.

"After conducting this study at FDA standards, we concluded that we deliver the highest quality care with results equal to any technology in use today. Further, customer satisfaction rates were very high, validating our internal LasikPlus® surveys. In fact, 95 percent of our patients would recommend LasikPlus® to a friend or co-worker according to our most recent monthly survey," added Dr. Groden.

"We're thrilled to now be able to offer our patients even greater confidence by showing independent research that verifies the quality of procedures performed on these modern platforms," he added. "Excimer technology has come a long way since FDA approval of photorefractive keratectomy in late 1995."

For more information about the ASCRS Symposium or the research, visit http://www.ascrs.org/11am/index.cfm.

About LCA-Vision/LasikPlus®

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, operates 54 LasikPlus® fixed-site laser vision correction centers in 26 states and 41 markets in the United States. Since the FDA approved photorefractive keratectomy in late 1995, we have performed nearly 1.2 million laser vision correction procedures at our vision centers.

LasikPlus® is partnering with the Wounded Warrior Project and the Fisher House Foundation to provide free LASIK services to wounded American veterans and their caregivers. To date, this partnership has led to the corrective surgery for nearly 100 wounded warriors and caregiversputting their lives back in focus. For additional company information, please visit www.lasikplus.com.

Contacts:

Jennifer Riegert


513-271-7222 x 22 (Office)


513-309-2920 (Cell)


jriegert@wordsworthweb.com



SOURCE LCA-Vision Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES